Innovative Cellular Therapeutics Holdings Ltd
SEC insider (Form 3/4/5 filer). CIK 0002095697. 10% Owner at Lyell Immunopharma, Inc. (LYEL). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in GEORGE TOWN.
Companies Innovative Cellular Therapeutics Holdings Ltd has filed insider reports for
- Lyell Immunopharma, Inc. (LYEL): 10% Owner
Innovative Cellular Therapeutics Holdings Ltd
CIK: 0002095697
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)4 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LYEL
Lyell Immunopharma, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 27, 2026LYEL
Lyell Immunopharma, Inc.
OtherDirect44K shares- - Jul 27, 2026LYEL
Lyell Immunopharma, Inc.
OtherDirect38.5K shares- - Jul 17, 2026LYEL
Lyell Immunopharma, Inc.
SaleDirect10 shares at avg. $13.70$137 - Jul 16, 2026LYEL
Lyell Immunopharma, Inc.
SaleDirect10 shares at avg. $13.73$137.3 - Jun 29, 2026LYEL
Lyell Immunopharma, Inc.
OtherDirect76K shares- - Jun 15, 2026LYEL
Lyell Immunopharma, Inc.
OtherDirect66.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 27, 2026 | LYEL Lyell Immunopharma, Inc. | Other | 44,000 | - | $0 | Direct |
| Jul 27, 2026 | LYEL Lyell Immunopharma, Inc. | Other | 38,500 | - | $0 | Direct |
| Jul 17, 2026 | LYEL Lyell Immunopharma, Inc. | Sale | 10 | $13.70 | $137 | Direct |
| Jul 16, 2026 | LYEL Lyell Immunopharma, Inc. | Sale | 10 | $13.73 | $137 | Direct |
| Jun 29, 2026 | LYEL Lyell Immunopharma, Inc. | Other | 76,000 | - | $0 | Direct |
| Jun 15, 2026 | LYEL Lyell Immunopharma, Inc. | Other | 66,500 | - | $0 | Direct |
1-6 of 6 transactions